Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity
Table 2
EC50 concentrations against MeV L of resistance mutations induced by viral adaptation to ERDRP-0519 and GHP-88309, respectively.
Binding kinetics (KD) between MeV L1708 or MeV L1708 harboring resistance mutations and ERDRP-0519 or GHP-88309 are shown.